Peptide Half-Life Chart: The Complete Reference Guide for Researchers

Why Peptide Half-Life Matters in Research

When studying peptides, one of the most critical variables researchers track is half-life — the amount of time it takes for a peptide's concentration in a biological system to reduce by 50%. This single data point influences dosing intervals, bioavailability assessments, and experimental design across virtually every peptide research protocol.

Whether you are investigating growth hormone secretagogues, tissue-repair peptides, or neuropeptides, understanding half-life helps researchers interpret results more accurately and design more consistent studies. This guide provides a consolidated reference to the most commonly researched peptides and what current literature suggests about their stability and duration of action.

What Affects a Peptide's Half-Life?

Not all peptides are created equal when it comes to stability. Several factors influence how long a peptide remains active in a biological environment:

• Amino acid sequence: Peptides containing D-amino acids or unusual residues tend to resist enzymatic degradation longer than their L-amino acid counterparts.
• Molecular modifications: PEGylation, acetylation, and DAC (Drug Affinity Complex) technology can significantly extend a peptide's active window.
• Route of administration: Subcutaneous, intravenous, and intranasal delivery all yield different absorption profiles and degradation rates.
• Enzymatic environment: Peptidases and proteases in plasma and tissue rapidly break down unmodified peptides, shortening their effective duration.

Peptide Half-Life Chart: Key Research Compounds

The following reference chart compiles data from published animal studies and in-vitro research. These figures are approximate and may vary depending on the biological model used.

Tissue Repair and Recovery Peptides

• BPC-157: Estimated half-life of approximately 4 hours in plasma models. Research suggests its gastric-stable structure may support systemic availability via oral or subcutaneous routes. Bpc 157
• TB-500 (Thymosin Beta-4 fragment): Studies indicate a half-life ranging from 8 to 12 hours in rodent plasma, attributed to its larger peptide structure relative to shorter-chain compounds.
• GHK-Cu (Copper Peptide): Research models suggest a relatively short plasma half-life of 30 to 60 minutes, though tissue retention may extend its local activity significantly.

Growth Hormone Secretagogues

• CJC-1295 (without DAC): Modified GRF 1-29 demonstrates a half-life of roughly 30 minutes in plasma research models, consistent with its unmodified GHRH analog structure.
• CJC-1295 with DAC: The addition of Drug Affinity Complex technology dramatically extends the half-life to an estimated 6 to 8 days in animal research, enabling sustained GH pulse stimulation over extended windows. Cjc 1295
• Ipamorelin: A selective GHRP with an estimated half-life of approximately 2 hours in rodent plasma studies. Research suggests it produces a clean GH pulse with minimal effect on cortisol or prolactin at studied concentrations.
• GHRP-6: Studies indicate a shorter half-life of around 15 to 60 minutes, requiring more frequent dosing intervals in research protocols.
• Sermorelin: One of the shorter-acting GHRH analogs, with a plasma half-life of approximately 10 to 20 minutes in documented research models.
• Hexarelin: Research data suggests a half-life between 1 to 2 hours, with noted receptor desensitization upon repeated use in animal models.

Cognitive and Neuropeptides

• Semax: Intranasal delivery studies in animal models suggest a functional half-life of 20 to 40 minutes, though its downstream neurotrophic effects may persist considerably longer.
• Selank: Similar to Semax, Selank research indicates a short plasma half-life of approximately 1 to 3 minutes, yet its anxiolytic-like effects in animal models appear disproportionately extended relative to its molecular presence.
• DSIP (Delta Sleep-Inducing Peptide): Studies report a plasma half-life of roughly 30 to 40 minutes in animal research, with a notable tendency toward rapid tissue uptake.

Longevity and Immune Peptides

• Epithalon: This tetrapeptide demonstrates a short plasma half-life in the range of 30 minutes to 1 hour, though telomere-related research in animal models documents effects that extend well beyond its plasma window. Epithalon
• Thymosin Alpha-1 (Ta1): Research models suggest a plasma half-life of approximately 2 hours, with strong resistance to degradation attributed to its acetylated N-terminus.
• LL-37 (Antimicrobial Peptide): Studies indicate a highly variable half-life between 30 minutes and several hours depending on the biological matrix, as serum proteins significantly influence its stability.

Half-Life vs. Duration of Effect: An Important Distinction

Researchers should note that plasma half-life is not the same as duration of biological effect. Many peptides, particularly neuropeptides and epigenetic modulators like Epithalon, exert downstream effects through receptor signaling cascades, gene expression changes, or growth factor upregulation — processes that can persist long after the parent compound has been cleared from plasma.

This distinction is especially relevant when designing wash-out periods in research protocols and interpreting results from longer-term animal studies. Always cross-reference half-life data with the specific endpoint being measured in your research design.

Storage and Stability: Preserving Peptide Integrity

Half-life data in biological systems is only one piece of the stability picture. In storage conditions, peptide degradation is primarily driven by temperature, light exposure, and oxidation. Research-grade peptides from Maxx Laboratories are lyophilized (freeze-dried) to maximize shelf stability. Studies indicate that reconstituted peptides stored at 4°C in bacteriostatic water remain stable for up to 4 weeks, while lyophilized powder stored at -20°C may retain integrity for 12 to 24 months under ideal conditions.

Always protect peptide vials from direct light, avoid repeated freeze-thaw cycles, and use sterile technique during reconstitution to maintain research-grade purity.

Using This Reference in Your Research

This peptide half-life chart is intended as a starting point — not a definitive protocol guide. Biological variability between species, individual subject differences, and the specific matrix studied (whole blood, plasma, tissue) all influence how these numbers translate to your experimental model.

For the most current data, cross-reference this guide with PubMed-indexed literature and consult the primary studies cited in your chosen compound's research dossier. Maxx Laboratories provides batch-specific HPLC purity certificates with all research compounds to support accurate, reproducible research outcomes.